← Back to guidelines
Neurosurgery11 papers

Meningoencephalomyelitis

Last edited: 4/15/2026

Overview

Non-infectious meningoencephalomyelitis (NIME) in dogs is a complex neurological disorder characterized by inflammation of the meninges and brain parenchyma, often challenging to diagnose ante mortem due to overlapping clinical and diagnostic features with other conditions.

Diagnosis

  • Cerebrospinal Fluid (CSF) Analysis: Utilize quantitative proteomics to identify differential protein abundance; notable up-regulated proteins include immunoglobulins, inter-alpha-trypsin inhibitor heavy chain 2, acid sphingomyelinase-like phosphodiesterase, and chitinase 3-like protein 1 1.
  • Control Group Comparison: Compare CSF profiles with conditions like intervertebral disc disease (IVDD) to highlight specific biomarkers 1.
  • Limited Serum Biomarkers: Serum profiles did not show significant differences, suggesting CSF analysis may be more informative 1.
  • Management

  • No Specific Drug Doses Mentioned: Current evidence does not provide specific drug classes or dosing recommendations for NIME management 1.
  • Immune Modulation: Consider therapies targeting immune response given the involvement of immune-related proteins in CSF 1.
  • Supportive Care: Focus on supportive neurological care, including management of symptoms and complications 1.
  • Special Populations

  • No Specific Data Provided: The abstracts do not cover special populations such as pregnancy, pediatrics, elderly, or comorbidities 1.
  • Key Recommendations

  • Utilize quantitative proteomics in CSF analysis for identifying potential biomarkers in dogs suspected of having NIME (Evidence: Moderate) 1.
  • Compare CSF profiles with non-neurological conditions like IVDD to enhance diagnostic accuracy (Evidence: Moderate) 1.
  • Consider immune modulation strategies in treatment plans due to the prominent role of immune response proteins (Evidence: Expert opinion) 1.
  • References

    1 Aradillas-Pérez M, Espinosa-López EM, Ortiz-Guisado B, Martín-Suárez EM, Gómez-Baena G, Galán-Rodríguez A. Quantitative proteomics analysis of cerebrospinal fluid reveals putative protein biomarkers for canine non-infectious meningoencephalomyelitis. Veterinary journal (London, England : 1997) 2025. link

    Original source

    1. [1]
      Quantitative proteomics analysis of cerebrospinal fluid reveals putative protein biomarkers for canine non-infectious meningoencephalomyelitis.Aradillas-Pérez M, Espinosa-López EM, Ortiz-Guisado B, Martín-Suárez EM, Gómez-Baena G, Galán-Rodríguez A Veterinary journal (London, England : 1997) (2025)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG